Article
Functional activation of mutant human insulin receptor by monoclonal antibody.
Lancet (London, England) - 8 Jun 1996
Krook A, Soos M A, Kumar S, Siddle K, O'Rahilly S
Abstract excerpt
BACKGROUND: A mutant insulin receptor, Ser323Leu, has been reported in two severely insulin-resistant patients with Rabson-Mendenhall syndrome. In both cases, extreme hyperglycaemia could not be controlled by conventional antidiabetic therapy. The SER323Leu mutant insulin receptor is inserted normally in the plasma membrane but has very low binding affinity for insulin. A monoclonal antibody directed against the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
